Section Arrow
SBFM.NASDAQ
- Sunshine Biopharma Inc
Quotes are at least 15-min delayed:2025/07/04 19:34 EDT
Last
 1.55
-0.1 (-6.06%)
Day High 
1.65 
Prev. Close
1.65 
1-M High
1.8132 
Volume 
292.84K 
Bid
1.52
Ask
1.6
Day Low
1.53 
Open
1.65 
1-M Low
1.39 
Market Cap 
7.52M 
Currency USD 
P/E
%Yield -- 
10-SMA 1.47 
20-SMA 1.52 
50-SMA 1.45 
52-W High 7.596 
52-W Low 1.1693 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-5.76/--
Enterprise Value
8.26M
Balance Sheet
Book Value Per Share
4.98
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
24.09M
Operating Revenue Per Share
3.19
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
TLRYTilray Brands0.5387+0.0535+11.03%-- 
RGCRegencell Bioscience Holdings Limited22.99+12.63+121.91%-- 
CGCCanopy Growth Corp1.28+0.09+7.56%-- 
IXHLIncannex Healthcare0.2094+0.0025+1.21%-- 
HLNHaleon plc10.25-0.01-0.10%23.95PE
Quotes are at least 15-min delayed:2025/07/04 19:34 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.